Optional increase dosage: 1.0 mg for at least 4 weeks 2.0 mg a week (This is the current maximum dose for Ozempic) Eapen, MD, says, The decision to increase beyond 0.5 mg depends on your individual needs, how well you tolerate the medication, and your treatment goals
January 2024: The National Library of Medicine published a case report documenting gastroparesis development in a patient using semaglutide for weight reduction, though causation remained unestablished
Across all of its GLP-1-related content, Henry advertises the substance as a weight loss drug and certain GLP-1 RAs have recently been FDA-approved to treat overweight and obesity
Traveling during the transition If you travel frequently, plan your switch timing carefully
R&D, Improving Health 01:00:01 Sponsors: AG1 & Levels 01:02:55 Lowering IDC?, Endowments, Monetary Distribution, Scientific Groupthink 01:12:29 Grant Review Process, Innovation 01:21:43 R01s, Tenure, Early Career Scientists & Novel Ideas 01:31:46 Sociology of Grant Evaluation, Careerism in Science, Failures 01:39:08 Sick Care System, Health Needs 01:44:01 Sponsor: LMNT 01:45:33 Incentives in Science, H-Index, Replication Crisis 01:58:54 Scientists, Data Fraud, Changing Careers 02:03:59 NIH & Changing Incentive Structure, Replication, Pro-Social Behavior 02:15:26 Scientific Discovery, Careers & Changing Times, Journals & Publications 02:19:56 NIH Grants & Appeals, Under-represented Populations, DEI 02:28:58 Inductive vs Deductive Science
Multiple sclerosis GLP-1 receptor agonists show neuroprotective properties that extend to autoimmune conditions of the central nervous system
&srotate=0)
